@Fortis_Healthcare_L has raised R37.7 Cr through a preferential allotment of 3.7 million shares to Standard Chartered Private Equity Mauritius III Ltd, BSE filing stated. With this, Fortis has cumulatively raised R1040 Cr this year through equity and equity-linked instruments.
The cumulative investment by SCPE in the company is estimated at about R250 Cr.
SCPE entities acting in concert with SCPE, had previously invested in the IPP of the company and have also recently intimated to the stock exchanges that they are the key investor in the public issue of FCCBs that the company listed on the Singapore Stock Exchange in July 2013.
Other investor - The @IFC has so far invested almost R570 Cr in the company through the IPP in May, a preferential allotment of equity shares and subscription to the FCCB issue in June.
Fortis Healthcare, which is turning its focus for future growth to the Indian healthcare market, is looking at a potential bed capacity of around 10,000 beds from its currently operational capacity of around 4,000 beds, in future. The company is expecting its business portfolio to continue with 80% domestic business and 20% international business.
Recently, it announced that one of its step down subsidiaries based out of Singapore, Fortis Healthcare International Pte, has completed divestment of its entire holding in its Vietnamese subsidiary Fortis Hoan My Medical Corporation, VOF PE Holding2 and Swindon to Viva Holdings Vietnam (Pte) for an aggregate consideration of $80 Mn.
Kerala-based Meditrina Hospitals has raised R40 Cr from Matrix Partners India for minority stake, BL stated. Meditrina plans to open a centre each within six months in Hyderabad and Bhubaneswar and a centre of excellence in Kollam with the funding.
Johnson&Johnson is planning to sell of its two FMCG brands which include Savlon antiseptic soap and liquids, and Shower to Shower talcum powder brands in India for a consideration value of above INR 3000 Mn.
DealCurry tracks financial and corporate markets for events, interprets and integrates the information in our platform, providing premium data, news and analytics. DealCurry provides comprehensive coverage of the capital markets through an intuitive, user-friendly interface.